Type of resection and prognosis in lung cancer. Experience of a multicentre study

European Journal of Cardio-thoracic Surgery

Volumn 28, Issue 4, 2005, Pages 622-628

  Rami Porta, Ramón ^a   Mateu Navarro, Miquel ^a   Freixinet, Jordi ^b   De La Torre, Mercedes ^c   Torres García, Antonio José ^d   Pun, Yat Wah ^e   Armengod, Antonio Cantó ^f  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL UNIVERSITARIO DE GRAN CANARIA DR NEGRÍN   (Spain)

^c HOSPITAL JUAN CANALEJO   (Spain)

^d HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^e HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^f HOSPITAL GENERAL UNIVERSITARIO DE VALENCIA   (Spain)

Author keywords

Complete resection in lung cancer; Lung cancer surgery; Resection for lung cancer

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SURGERY; FEMALE; HUMAN; LUNG CANCER; LUNG CARCINOMA; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM LYMPH NODE; PLEURA EFFUSION; PRIORITY JOURNAL; PROGNOSIS; SMALL CELL CARCINOMA; SURGICAL MORTALITY; SURVIVAL; THORACOTOMY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, BRONCHOGENIC; HUMANS; LUNG NEOPLASMS; LYMPH NODES; MEDIASTINUM; MIDDLE AGED; NEOPLASM STAGING; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS; THORACOTOMY; TREATMENT OUTCOME;

EID: 25144503021     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2005.06.026     Document Type: Article

References (23)

1. N. Martini, and R.J. Ginsberg Surgical management F.G. Pearson J. Deslauriers R.J. Ginsberg C.A. Hiebert M.F. McKneally H.C. Urschel Jr Thoracic surgery 1995 Churchill Livingston New York 690 705
2. T. Naruke, K. Suemasu, and S. Ishikawa Lymph node mapping and curability at various levels of metastasis in resected lung cancer J Thorac Cardiovasc Surg 76 1978 832 839
3. C.F. Mountain Biologic, physiologic, and technical determinants in surgical therapy for lung cancer M.J. Straus Lung cancer 2nd ed Clinical diagnosis and treatment 1983 Grune and Stratton New York 245 260
4. P.A. Thomas, S. Piantadosi, C.F. Mountain The Lung Cancer Study Group Should subcarinal lymph nodes be routinely examined in patients with non-small cell lung cancer? J Thorac Cardiovasc Surg 95 1988 883 887
5. L.H. Sobin, and C.h. Wittekind UICC international union against cancer, TNM classification of malignant tumours 6th ed. 2002 Wiley-Liss New York
6. Grupo Cooperativo de Carcinoma Broncogénico de SEPAR (GCCB-S) Cirugía del carcinoma broncogénico en España. Estudio descriptivo Arch Bronconeumol 31 1995 303 309
7. A. López Encuentra, and the Bronchogenic Carcinoma Cooperative Group of the Spanish Society of Pneumology and Thoracic Surgery (GCCB-S) Criteria of functional and oncological operability in surgery for lung cancer. A multicenter study Lung Cancer 20 1998 161 168
8. A. López Encuentra, A. Gómez de la Cámara, and for the Bronchogenic Carcinoma Cooperative Group of the Spanish Society of Pneumology and Thoracic Surgery (GCCB-S) Validation of a central review board of staging prior to surgery for non-small-cell lung cancer - impact on prognosis: a multicenter study Respiration 69 2002 16 24
9. López Encuentra A, Gómez de la Cámara A, Varela de Ugarte A, Mañes N, Llobregat N y GCCB-S. El 'fenómerno Will-Rogers'. Migración de estadios en carcinoma broncogénico, tras aplicar criterios de certeza clasificatoria. Arch Bronconeumol; 2002; 38: 166-71.
10. American Thoracic Society: Clinical staging primary lung cancer Am Rev Respir Dis 127 1983 659 664
11. J.R. Izbicki, B. Passlick, O. Karg, C. Bloechle, K. Pantel, W.T. Knoefel, and Olaf Thetter Impact of radical systematic mediastinal lymphadenectomy on tumor staging in lung cancer Ann Thorac Surg 59 1995 209 214
12. Grupo Cooperativo de Carcinoma Broncogénico de SEPAR (GCCB-S) Control de calidad en un registro multiinstitucional de carcinoma broncogénico Arch Bronconeumol 32 suppl 2 1996 32 70
13. Grupo de Trabajo SEPAR Normativa sobre nomenclatura y clasificación del carcinoma broncogénico 1986 Ediciones Doyma, SA, Barcelona
14. C.F. Mountain, J.M. Lukeman, S.P. Hammar, D.W. Chamberlain, W.F. Coulson, D.L. Page, and the Lung Cancer Study Group Pathology Committee Lung cancer classification: the relationship of disease extent and cell type to survival in a clinical trials population J Surg Oncol 35 1987 147 156
15. J.R. Izbicki, B. Passlick, K. Pantel, U. Pichlmeier, S.B. Hosch, O. Karg, and O. Thetter Effectiveness of radical sysematic mediastinal lymphadenectomy in patients with resectable non-small cell lung cancer Am Surg 227 1998 138 144
16. S.M. Keller, S. Adak, H. Wagner, D.H. Johnson Eastern Cooperative Oncology Group Mediastinal lymph node dissection improves survival in patients with stages II and IIIa non-small cell lung cancer Ann Thorac Surg 70 2000 358 366
17. P. Goldstraw Report in the International workshop on intrathoracic staging, London, October 1996 Lung Cancer 18 1997 107 111
18. J.F. Vansteenkiste, P.R. De Leyn, G.J. Deneffe, G. Stalpaert, K.L. Nackaerts, T.E. Lerut, Maurits G. Demedts, and the Leuven Lung Cancer Group Survival and prognostic factors in resected N2 non-small cell lung cancer: a study of 140 cases Ann Thorac Surg 63 1997 1441 1450
19. R. Rami Porta, M. Mateu Navarro, G. González Pont, and M. Cuesta Palomero Resultados del tratamiento quirúrgico del carcinoma broncogénico N2 patológico con mediastinoscopia negativa Arch Bronconeumol 36 2000 365 370
20. R.J. Snijder, A. Brutel de la Rivière, H.J.J. Elbers, and J.M.M. Van den Bosch Survival in resected stage I lung cancer with residual tumor at the bronchial resection margin Ann Thorac Surg 65 1998 212 216
21. G. Massard, C. Doddoli, B. Gasser, X. Ducrocq, R. Kessler, C. Schumacher, G.-M. Jung, and J.-M. Wihlm Prognostic implications of a positive bronchial resection margin Eur J Cardio-Thorac Surg 17 2000 557 565
22. C. Bebitekin, N.K. Gupta, C.M.R. Satur, G. Olgac, P.G. Martin, N.R. Saunders, and D.R. Walker Fate of patients with residual tumours at the bronchial resection margin Eur J Cardiothorac Surg 8 1994 339 344
23. C. Wittekind, C.C. Compton, F.L. Greene, and L.H. Sobin TNM residual tumor classification revisited Cancer 94 2002 2511 2519